trump on glp-1 Big News: medicine prices drop after US President Trump’s announcement Nov 6 The Trump Administration is delivering

An uncontrolled UK-based study found that optimising glycaemic control with continuous subcutaneous insulin infusions in people with diabetic gastroparesis resulted in substantial reductions in hospitalisation, although this requires corroboration in other trials

Pediatric patients, adults, and immunocompromised individuals often require distinct formulations and dosing strategies

Proactive fertility planning: parallel assessments of fertility and metabolic risk should be conducted during the early 20s and 30s

More on GLP-1s: Trump Strikes Deal to Offer Americans GLP-1 Drugs for Much Cheaper

& Haynes, R

Compounded tirzepatide ranges from $150 to $500 per month